MedPath

Psychometric Properties of the Chinese Version of the Five-item Relationship Satisfaction Scale

Recruiting
Conditions
Relationship, Family
Interventions
Other: Questionnaires set
Registration Number
NCT05494996
Lead Sponsor
Sun Yat-sen University
Brief Summary

The aims of this study are to translate the five-item relationship satisfaction scale(RS5) into Chinese and assess its psychometric properties among Chinese patients.

Detailed Description

This study will use forward translation, reverse translation, and comprehensive methods to translate the RS5 scale into Chinese ,which will be more in line with the Chinese language and cultural environment. This study will also verify its reliability and validity in a large sample population to form a formal version of the scale. The scale will provide an effective tool for evaluating the degree of relationship satisfaction in China.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
278
Inclusion Criteria
  • ≥18 years old;
  • Participants who are married or in a romantic relationship;
  • Be able to read and communicate in Chinese.
Exclusion Criteria
  • Those who are unable to communicate due to serious mental or physical illnesses such as deafness, confusion caused by mental illness, etc.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Questionnaires assessed partnersQuestionnaires set1. ≥18 years old; 2. Participants who are married or in a romantic relationship; 3. Be able to read and communicate in Chinese.
Primary Outcome Measures
NameTimeMethod
Relationship satisfactionBaseline

The five-item relationship satisfaction scale(RS5)is a validated self-reported instrument assessing e-cigarette dependence.It consists of five items which are rated on a 6-point Likert scale (1 = Strongly disagree, 6 = Strongly agree).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

XIAW

🇨🇳

Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath